. 2021 Mar 12;60(8):3496–3502. doi: 10.1093/rheumatology/keab223
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Fig. 1.
Factors influencing rituximab treatment decisions